These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9723044)

  • 41. Treatment of palmar hyperhidrosis with botulinum neurotoxin a.
    Mannava S; Mannava KA; Nazir OF; Plate JF; Smith BP; Koman LA; Tuohy CJ
    J Hand Surg Am; 2013 Feb; 38(2):398-400. PubMed ID: 23267759
    [No Abstract]   [Full Text] [Related]  

  • 42. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The ultimate antiperspirant. Botox injections have many uses, including the treatment of excessive sweating.
    Harv Health Lett; 2003 Jul; 28(9):6. PubMed ID: 12888471
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H; Briand N; Bara C; Celerier P
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
    Schnider P; Binder M; Kittler H; Birner P; Starkel D; Wolff K; Auff E
    Br J Dermatol; 1999 Apr; 140(4):677-80. PubMed ID: 10233320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum neurotoxin treatment of palmar and plantar hyperhidrosis.
    Weinberg T; Solish N; Murray C
    Dermatol Clin; 2014 Oct; 32(4):505-15. PubMed ID: 25152344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperhidrosis treated by botulinum A exotoxin.
    Odderson IR
    Dermatol Surg; 1998 Nov; 24(11):1237-41. PubMed ID: 9834745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of Injection Site Pain in the Treatment of Axillary Hyperhidrosis With Botulinum Toxin: A Randomized, Side-by-Side, Comparative Study of Two Injection Patterns.
    Awaida CJ; Rayess YA; Jabbour SF; Abouzeid SM; Nasr MW
    Dermatol Surg; 2021 Jan; 47(1):154-157. PubMed ID: 31592920
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
    Nawrocki S; Cha J
    J Am Acad Dermatol; 2020 Apr; 82(4):969-979. PubMed ID: 31811879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idiopathic localized unilateral hyperhidrosis: case report of successful treatment with botulinum toxin type A and review of the literature.
    Kreyden OP; Schmid-Grendelmeier P; Burg G
    Arch Dermatol; 2001 Dec; 137(12):1622-5. PubMed ID: 11735712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis.
    Lynch OE; Aherne T; Gibbons J; Boland MR; Ryan ÉJ; Boyle E; Egan B; Tierney S
    Ir J Med Sci; 2020 Aug; 189(3):1023-1026. PubMed ID: 31898163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective treatment of frontal hyperhidrosis with botulinum toxin A.
    Kinkelin I; Hund M; Naumann M; Hamm H
    Br J Dermatol; 2000 Oct; 143(4):824-7. PubMed ID: 11069464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a grid to simplify botulinum toxin injection for axillary hyperhidrosis.
    Lam DG; Choudhary S
    Plast Reconstr Surg; 2003 Nov; 112(6):1741-2. PubMed ID: 14578822
    [No Abstract]   [Full Text] [Related]  

  • 60. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.